Previous studies have demonstrated that AQP8 expression is downregulated in liver diseases such as cholestasis, hepatic steatosis, and NAFLD, leading to hepatocyte swelling and lipid accumulation due to impaired water transport [10,11,12]. This evidence concerns the gene AQP8 and metabolic dysfunction-associated steatotic liver disease.